Innovative treatments and risk adaptive therapies for myeloma May 25, 2021 Overview Show transcript Overview Multiple myeloma can present very differently from patient to patient, which is why access to innovations in both diagnostics and treatments is important when determining the best possible care. Experts from Mayo Clinic Cancer Center discuss distinctions between myelomas, the process to an accurate diagnosis, the approach to risk adaptive therapies and their vision for multiple myeloma treatment in the future. Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoAdvances for multiple myeloma treatmentsArticleMayo Clinic-developed mass spectrometry assay improves detection of monoclonal proteins, advancing outcomes in hard-to-treat diseases VID-20515326 Medical Professionals Innovative treatments and risk adaptive therapies for myeloma